Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BHVN | Common Shares | Options Exercise | $153K | +250K | +66.86% | $0.61* | 624K | Nov 16, 2021 | Direct | |
transaction | BHVN | Common Shares | Options Exercise | $980K | +175K | +28.05% | $5.60* | 799K | Nov 16, 2021 | Direct | |
transaction | BHVN | Common Shares | Options Exercise | $465K | +50K | +6.26% | $9.29* | 849K | Nov 16, 2021 | Direct | |
transaction | BHVN | Common Shares | Options Exercise | $518K | +18K | +2.12% | $28.76* | 867K | Nov 16, 2021 | Direct | |
transaction | BHVN | Common Shares | Options Exercise | $1.11M | +18K | +2.08% | $61.76* | 885K | Nov 16, 2021 | Direct | |
transaction | BHVN | Common Shares | Options Exercise | $325K | +30K | +3.39% | $10.82* | 915K | Nov 16, 2021 | Direct | |
transaction | BHVN | Common Shares | Options Exercise | $848K | +18K | +1.97% | $47.10* | 933K | Nov 16, 2021 | Direct | |
transaction | BHVN | Common Shares | Sale | -$1.44M | -12.4K | -1.33% | $115.90* | 920K | Nov 16, 2021 | Direct | F1 |
transaction | BHVN | Common Shares | Sale | -$2.13M | -18.2K | -1.98% | $116.69* | 902K | Nov 16, 2021 | Direct | F2 |
transaction | BHVN | Common Shares | Sale | -$834K | -7.07K | -0.78% | $117.87* | 895K | Nov 16, 2021 | Direct | F3 |
holding | BHVN | Common Shares | 626K | Nov 16, 2021 | By the Declan Doogan 2014 Trust |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BHVN | Stock Option (Right to buy) | Options Exercise | $0 | -250K | -100% | $0.00* | 0 | Nov 16, 2021 | Common Shares | 250K | $0.61 | Direct | F4 |
transaction | BHVN | Stock Option (Right to buy) | Options Exercise | $0 | -175K | -100% | $0.00* | 0 | Nov 16, 2021 | Common Shares | 175K | $5.60 | Direct | F5 |
transaction | BHVN | Stock Option (Right to buy) | Options Exercise | $0 | -50K | -100% | $0.00* | 0 | Nov 16, 2021 | Common Shares | 50K | $9.29 | Direct | F6 |
transaction | BHVN | Stock Option (Right to buy) | Options Exercise | $0 | -18K | -100% | $0.00* | 0 | Nov 16, 2021 | Common Shares | 18K | $28.76 | Direct | |
transaction | BHVN | Stock Option (Right to buy) | Options Exercise | $0 | -18K | -100% | $0.00* | 0 | Nov 16, 2021 | Common Shares | 18K | $61.76 | Direct | |
transaction | BHVN | Stock Option (Right to buy) | Options Exercise | $0 | -30K | -100% | $0.00* | 0 | Nov 16, 2021 | Common Shares | 30K | $10.82 | Direct | F7 |
transaction | BHVN | Stock Option (Right to buy) | Options Exercise | $0 | -18K | -100% | $0.00* | 0 | Nov 16, 2021 | Common Shares | 18K | $47.10 | Direct |
Id | Content |
---|---|
F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.31 - $116.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.32 - $117.31, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.33 - $118.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4. |
F4 | The shares underlying this option vested as to 25% of the shares on November 26, 2014, and the remainder vested in 3 equal installments on the first, second and third anniversaries of the grant date. |
F5 | The shares underlying this option vested as to 25% of the shares on October 23, 2015, and the remainder vested in 3 equal installments on the first, second and third anniversaries of the grant date. |
F6 | The shares underlying this option vested as to 25% of the shares on December 15, 2016, and the remainder vested in 3 equal installments on the first, second and third anniversaries of the grant date. |
F7 | The shares underlying this option vested as to 25% of the shares on April 6, 2017, and the remainder vested in 3 equal installments on the first, second and third anniversaries of the grant date. |